4/28, 1:03 PM (Source: TeleTrader)
more TeleTrader news

GSK sales drop 18% to £7.4 billion in Q1

GlaxoSmithKline PLC (GSK) announced on Wednesday its sales in the first quarter of 2021 amounted to £7.4 billion, dropping 18% from the same period in 2020.

Earnings per share (EPS) plunged 32% year on year to 21.5 pence, while adjusted EPS plummeted 39% to 22.9 pence. Operating profit stood at £1.7 billion, falling 16% from the first trimester of 2020, and adjusted operating profit fell 30% to £1.9 billion.

"Our first-quarter results are in line with our expectations and reflect the anticipated impacts of COVID-19. We continue to expect a significant improvement in performance over the remainder of the year and reconfirm our guidance for 2021 and 2022 outlook," CEO Emma Walmsley stated.

Breaking the News / NP